Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Temporarily not available 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3NIH 1

Study Type

Observational 1Interventional 1Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

spartalizumab 1Taxes 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Locally Advanced Pancreatic Adenocarcinoma × Clear all
NCT07319910 2026-01-06

PANOVA-3CA

NovoCure Ltd.

Temporarily not available
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT05607953 2025-07-04

Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma

TriSalus Life Sciences, Inc.

Phase 1 Active not recruiting
60 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT06399172 2024-05-03

OSPRItaly

OncoSil Medical Limited

Not yet recruiting
50 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡